Europe Poultry Vaccines Market Forecast to 2031
Europe Poultry Vaccines Market Forecast to 2031 – Regional Analysis – by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Marek’s Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
$2,760 – $4,360
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Poultry Industry Drives Europe Poultry Vaccines Market
According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world’s largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world’s poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.
Europe Poultry Vaccines Market Overview
In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of “male brother chicks” of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.
Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)
Europe Poultry Vaccines Market Segmentation
The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.
In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.
Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is anticipated to reach US$ 635.01 million by 2031, registering a CAGR of 8.9% from 2023 to 2031. Government support for mass vaccination drives and innovative schemes and advancements in vectored and combination vaccines are among the critical factors attributed to drive the Europe poultry vaccines market growth.
Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.
• In April 2023, the government of France announced passing a tender for ordering 80 million doses of avian influenza vaccines as the country was preparing for a mass vaccination program. The “ANES” Ministry in France was the first country in the European Union (EU) to start such a mass vaccination scheme. For conducting such a mass vaccination drive, France mandated 2 companies, France’s Ceva Animal Health and Germany’s Boehringer Ingelheim, to develop avian influenza vaccines. Both vaccines by the two companies effectively protect birds against the virus.
• In recent years, there has been an outbreak of highly pathogenic avian influenza (HPAI) in both domestic and wild birds throughout the European Union (EU). In order to stop and manage the spread of HPAI, vaccination may be taken into consideration in addition to currently in place strategies (such as surveillance, biosecurity, and early identification). As mandated by EU regulation, post-vaccination improved surveillance of vaccinated poultry is necessary to show that vaccinated areas are free of HPAI and to identify any possible outbreaks of the virus early on. In May 2024, MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA announced that the INNOVAX-ND-H5 vaccination for chickens has received marketing authorization from the European Commission. This vaccination protects poultry from the avian influenza virus strains of clade 2.3.4.4b that are currently in circulation, which have a high fatality rate. It is the first vaccination to be centrally registered in the European Union. Any vaccination against HPAI should be administered in compliance with government rules and tandem with stringent biosecurity and surveillance measures.
Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.
On the contrary, vaccination failure and improper handling hampers the growth of Europe poultry vaccines market.
Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held 58.3% market share in 2023, amassing US$ 187.49 million. It is projected to garner US$ 380.86 million by 2031 to register 9.3% CAGR during 2023-2031.
In terms of technology, the Europe poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held 51.2% share of Europe poultry vaccines market in 2023, amassing US$ 164.71 million. It is projected to garner US$ 329.55 million by 2031 to register 9.1% CAGR during 2023-2031.
By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held 53.1% share of Europe poultry vaccines market in 2023, amassing US$ 170.88 million. It is projected to garner US$ 348.75 million by 2031 to expand at 9.3% CAGR from 2023 to 2031.
Based on type of disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held 29.6% share of Europe poultry vaccines market in 2023, amassing US$ 95.16 million. It is predicted to garner US$ 197.39 million by 2031 to expand at 9.5% CAGR between 2023 and 2031.
By route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held 41.9% share of Europe poultry vaccines market in 2023, amassing US$ 134.86 million. It is estimated to garner US$ 277.33 million by 2031 to expand at 9.4% CAGR during 2023-2031.
In terms of end user, the Europe poultry vaccines market is categorized into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held 50.9% share of Europe hearing aids market in 2023, amassing US$ 163.73 million. It is projected to garner US$ 336.00 million by 2031 to expand at 9.4% CAGR from 2023 to 2031.
Based on country, the Europe poultry vaccines market is categorized into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe poultry vaccines market in 2023. It was assessed at US$ 96.06 million in 2023 and is likely to hit US$ 198.76 million by 2031, registering a CAGR of 9.5% during 2023-2031.
Key players operating in the Europe poultry vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB, among others.
In June 2023, Zoetis announced launching of “CircoMax” in Europe. This new product is the effective against Porcine Circovirus Type 2 (PCV2) vaccine that includes two genotypes (A and B) providing broad coverage and protection against PCV2 threat. Also, CircoMax has demonstrated protection against PCV2a, PCV2b, and PCV2d.
In February 2019, Phibro Animal Health will introduce its new Provide Prime direct-fed microbial product that helps optimize the gut microbiome for improved health, immunity, and productivity in poultry. Provia™ Prime is in a class of Bacillus-based Direct-Fed Microbials (DFMs) that have been shown to promote beneficial gut bacteria, which can help improve immunity, foster gut health and act as natural growth promoters. It includes a patent-pending proprietary combination of four powerful probiotic strains of Bacillus subtilis, Bacillus licheniformis, Bacillus coagulans and Bacillus amyloliquefaciens. Together these four strains create a synergistic effect that encourage a higher population in the gut of “good bacteria,” which can help support broiler health and increase yield.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe poultry vaccines market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. Europe Poultry Vaccines Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. Europe Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031
6. Europe Poultry Vaccines Market Analysis – by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7. Europe Poultry Vaccines Market Analysis – by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Poultry Vaccines Market Analysis – by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Poultry Vaccines Market Analysis – by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
9.3.1 Overview
9.3.2 Avian Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Marek’s Disease
9.4.1 Overview
9.4.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. Europe Poultry Vaccines Market Analysis – by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. Europe Poultry Vaccines Market Analysis – by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. Europe Poultry Vaccines Market – Country Analysis
12.1 Europe Market Overview
12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
12.1.1.1 Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
12.1.1.2 Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
12.1.1.3 France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
12.1.1.4 United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Overview
12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
12.1.1.5 Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
12.1.1.6 Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Overview
12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Elanco Animal Health Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Ceva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Vaccinova AB
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Research Team
15.2 Glossary of Terms
Table 1. Europe Poultry Vaccines Market Segmentation
Table 2. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 7. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 13. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 19. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 21. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 22. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 23. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 24. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 25. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 27. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 28. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 29. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 30. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 31. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 32. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 33. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 34. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 35. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 36. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 37. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 38. Organic Developments Done by Companies
Table 39. Inorganic Developments Done by Companies
Table 40. Glossary of Terms, Poultry Vaccines Market
Figure 1. Europe Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
Figure 5. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 19. Marek’s Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) – by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 33. Europe: Poultry Vaccine Market – Revenue by Key Countries Revenue 2023 (US$ Million)
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 37. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 39. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 40. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 41. Growth Strategies in the Poultry Vaccines Market
The List of Companies – Europe Poultry Vaccines Market
o Boehringer Ingelheim International GmbH.
o Zoetis Inc.
o Phibro Animal Health Corp.
o Dechra Pharmaceuticals PLC.
o Elanco Animal Health Inc.
o Merck KGaA.
o Ceva.
o Vaccinova AB.
You must be logged in to post a review.
Reviews
There are no reviews yet.